India is facing a slow-moving public health emergency that rarely makes headlines but threatens the foundations of modern medicine. Antimicrobial Resistance (AMR), driven largely by the overuse and misuse of antibiotics, has now been flagged repeatedly by the country’s political leadership — including Prime Minister Narendra Modi, Home Minister Amit Shah and Health Minister JP Nadda. Their warnings underline the scale of a crisis that is no longer confined to hospitals but is steadily spilling into the community.
Why antimicrobial resistance is a national concern
AMR occurs when bacteria, viruses, fungi or parasites evolve to resist medicines designed to kill them. In practical terms, this means common infections become harder, costlier and sometimes impossible to treat. According to the Institute of Health Metrics and Evaluation, nearly 2.67 lakh deaths in India in 2021 were attributable to drug-resistant infections — a figure that places India among the worst-affected countries globally.
What makes AMR especially dangerous is that it undermines routine medical care. Surgeries, cancer chemotherapy, organ transplants and even childbirth depend on effective antibiotics to prevent infections. When these drugs stop working, the entire health system becomes vulnerable.
How serious is AMR in India today?
India’s burden of AMR is both hospital-based and community-driven. Hospitals, where antibiotic use is intense, act as pressure cookers for resistance. Bacteria exposed repeatedly to antibiotics mutate, survive and pass resistance genes to other bacteria. Patients admitted for non-infectious conditions — heart disease, kidney failure or trauma — can end up acquiring deadly drug-resistant infections during treatment.
Community-acquired infections are also changing character. Diseases such as typhoid, pneumonia and diarrhoeal illnesses are increasingly showing resistance to commonly used drugs. With nearly 18% of the world’s population, India accounts for a disproportionate share of global drug-resistant infections.
The behavioural roots of antibiotic misuse
A major driver of AMR in India is behavioural. Antibiotics are often treated as quick fixes for coughs, colds and diarrhoea — even though most of these are viral and do not respond to antibiotics at all. Self-medication, pharmacist-led advice without prescriptions, and prophylactic antibiotic use by doctors have created a culture of casual consumption.
This learned behaviour has been reinforced over decades, making regulation alone insufficient unless accompanied by awareness and stewardship.
Does antibiotic stewardship actually work?
Evidence suggests it does — but slowly. Kerala’s antimicrobial stewardship programme, launched in 2015, focused on rational prescribing, hospital protocols and public awareness. Only after nearly a decade of groundwork did the State move to restrict over-the-counter antibiotic sales. The lesson is clear: bans without behavioural change are unlikely to succeed.
Stewardship works by reducing unnecessary antibiotic pressure. When certain drugs are used less, bacteria often regain sensitivity over time — a phenomenon already observed in diseases like typhoid.
Why routine infections are getting harder to treat
Doctors today face two overlapping challenges. One is treating infections caused by already drug-resistant bacteria, which require expensive “last-resort” antibiotics. The other is the gradual transformation of simple infections into complicated ones due to repeated, inappropriate antibiotic exposure.
Typhoid illustrates this well. Fluoroquinolones, once effective, are now widely resisted. Newer drugs such as ceftriaxone and azithromycin are being overused, risking the same fate. The experience of older drugs regaining effectiveness after periods of disuse shows that resistance is not always irreversible — but only if antibiotic pressure is reduced.
The role of diagnostics in fighting AMR
One of the strongest tools against AMR is accurate diagnosis. Under the National Health Mission, India’s Free Drugs and Diagnostics Services aim to ensure that patients are tested before being treated. Better diagnostics reduce blind prescribing of broad-spectrum antibiotics.
Strengthening laboratory capacity at the primary and secondary healthcare levels has already shown results, with patients relying less on unqualified practitioners when free testing is available.
Human behaviour versus animals and the environment
While antibiotic use in livestock and agriculture often draws attention, Indian studies suggest that the dominant driver of resistance remains human misuse. Research by found significant overlap of resistance genes between human and environmental samples near hospitals, but minimal overlap between human and animal isolates.
However, antibiotic residues in food can still affect the gut microbiome, turning harmless gut bacteria into reservoirs of resistance genes that can later infect humans or pass resistance to pathogens.
Why India lacks complete AMR data
India’s AMR surveillance network is currently concentrated in tertiary hospitals, where resistance levels are naturally higher due to heavy antibiotic exposure. While this data is valuable, it does not fully represent the national picture. Expanding surveillance to district hospitals and smaller facilities is essential for designing realistic policies.
Are there alternatives to antibiotics?
Emerging options such as phage therapy — using viruses that kill bacteria — show promise, particularly for urinary tract infections. However, they require precise matching between the pathogen and the phage, and resistance can still develop. Monoclonal antibodies are another avenue, but both approaches remain experimental and expensive, far from large-scale deployment.
What to note for Prelims?
- AMR refers to resistance of microbes to drugs meant to kill them.
- India is among the highest AMR-burden countries globally.
- ICMR runs India’s national AMR surveillance network.
- Antibiotic misuse is a key driver of resistance.
What to note for Mains?
- AMR as a threat to public health, economy and national security.
- Behavioural and systemic causes of antibiotic misuse in India.
- Role of diagnostics, stewardship and surveillance in tackling AMR.
- Limits of regulation without public awareness and institutional capacity.
AMR has been described as a “silent pandemic” for good reason. It advances quietly, without dramatic outbreaks, but steadily erodes the effectiveness of medicine. India’s challenge is not only to preserve the antibiotics it has, but to change how society understands and uses them — before routine infections once again become deadly.
Last Modified: January 26, 2026